The PE Ratio as of November 2024 (TTM) for Virpax Pharmaceuticals, Inc. (VRPX) is -0.08

According to Virpax Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of -69.89% compared to the average of -0.27 of the last 4 quarters.

Virpax Pharmaceuticals, Inc. (VRPX) Historical PE Ratio (quarterly & annually)

How has VRPX PE Ratio performed in the past?

The mean historical PE Ratio of Virpax Pharmaceuticals, Inc. over the last ten years is -23.88. The current -0.08 PE Ratio has changed -66.50% with respect to the historical average. Over the past ten years (40 quarters), VRPX's PE Ratio was at its highest in in the June 2024 quarter at -0.07. The PE Ratio was at its lowest in in the March 2020 quarter at -122.97.

Virpax Pharmaceuticals, Inc. (VRPX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Virpax Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Virpax Pharmaceuticals, Inc. (VRPX) Average PE Ratio

How has VRPX PE Ratio performed in the past?

The current PE Ratio of Virpax Pharmaceuticals, Inc. (VRPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Virpax Pharmaceuticals, Inc. (VRPX) PE Ratio vs. Peers

How is VRPX’s PE Ratio compared to its peers?

Virpax Pharmaceuticals, Inc.’s PE Ratio is less than Panbela Therapeutics, Inc. (-0.06), greater than Revelation Biosciences, Inc. (-0.13), greater than Palisade Bio, Inc. (-0.26), greater than Virax Biolabs Group Limited (-0.67), greater than Quoin Pharmaceuticals, Ltd. (-0.33), greater than ZIVO Bioscience, Inc. (-5.20), greater than RenovoRx, Inc. (-3.51), less than Pasithea Therapeutics Corp. (-0.00), greater than ARCA biopharma, Inc. (-58.03), greater than Nutriband Inc. (-7.34), greater than Longeveron Inc. (-1.44), greater than Blue Water Vaccines, Inc. (-0.26), greater than Hillstream BioPharma, Inc. (-0.99), less than Kiora Pharmaceuticals, Inc. (2.56), greater than Biodexa Pharmaceuticals Plc (-0.18), greater than Praxis Precision Medicines, Inc. (-9.32),

Build a custom stock screener for Virpax Pharmaceuticals, Inc. (VRPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virpax Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Virpax Pharmaceuticals, Inc. (VRPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Virpax Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.